Decreased basal ganglia activation in subjects with chronic fatigue syndrome: association with symptoms of fatigue.

PubWeight™: 0.88‹?›

🔗 View Article (PMC 4032274)

Published in PLoS One on May 23, 2014

Authors

Andrew H Miller1, James F Jones2, Daniel F Drake1, Hao Tian2, Elizabeth R Unger2, Giuseppe Pagnoni3

Author Affiliations

1: Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia, United States of America.
2: Chronic Viral Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
3: Department of Neuroscience, Biomedical, Metabolic Sciences, Università Degli Studi Di Modena E Reggio Emilia, Modena, Italy.

Articles cited by this

The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02

AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res (1996) 53.52

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med (1994) 26.24

Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci (1986) 18.17

A SELF-RATING DEPRESSION SCALE. Arch Gen Psychiatry (1965) 15.73

The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res (1995) 9.99

Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med (2001) 6.07

A community-based study of chronic fatigue syndrome. Arch Intern Med (1999) 6.04

Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev (1995) 5.23

Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med (2003) 4.46

Circuits and circuit disorders of the basal ganglia. Arch Neurol (2007) 3.97

Fatigue in neurological disorders. Lancet (2004) 3.45

Chronic fatigue syndrome--a clinically empirical approach to its definition and study. BMC Med (2005) 2.97

Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci (2005) 2.90

Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex (2005) 2.80

Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry (1996) 2.76

Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol (2010) 2.64

Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia. Popul Health Metr (2007) 2.58

The economic impact of chronic fatigue syndrome. Cost Eff Resour Alloc (2004) 2.47

Functional and pathophysiological models of the basal ganglia. Curr Opin Neurobiol (1996) 2.45

Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ (2006) 2.14

Ventral pallidum roles in reward and motivation. Behav Brain Res (2008) 2.12

Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neuropathol (2001) 2.09

Disentangling pleasure from incentive salience and learning signals in brain reward circuitry. Proc Natl Acad Sci U S A (2011) 2.09

Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol Psychiatry (2010) 1.95

Psychometric properties of the CDC Symptom Inventory for assessment of chronic fatigue syndrome. Popul Health Metr (2005) 1.94

Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol Psychiatry (2008) 1.85

Fatigue and basal ganglia. J Neurol Sci (2000) 1.82

Plasma cytokines in women with chronic fatigue syndrome. J Transl Med (2009) 1.55

Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration. Arch Gen Psychiatry (2012) 1.48

Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatry (1998) 1.37

Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front Neuroendocrinol (2012) 1.35

Apathy following stroke. Can J Psychiatry (2010) 1.26

Stress-associated changes in the steady-state expression of latent Epstein-Barr virus: implications for chronic fatigue syndrome and cancer. Brain Behav Immun (2005) 1.19

Anhedonia after a selective bilateral lesion of the globus pallidus. Am J Psychiatry (2006) 1.19

Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors. Appl Neuropsychol (2001) 1.18

Exacerbated physical fatigue and mental fatigue in Parkinson's disease. Mov Disord (2001) 1.18

Lateral asymmetry of neurotransmitters in human brain. Brain Res (1982) 1.16

Acute phase responses and cytokine secretion in chronic fatigue syndrome. J Clin Immunol (1999) 1.07

Forebrain circuitry involved in effort-related choice: Injections of the GABAA agonist muscimol into ventral pallidum alter response allocation in food-seeking behavior. Neuroscience (2008) 1.05

Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus. Neurosci Lett (2001) 1.03

A potential role for interferon-alpha in the pathogenesis of HIV-associated dementia. Brain Behav Immun (1995) 1.03

Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin. J Affect Disord (2011) 1.01

In vivo magnetic resonance spectroscopy in chronic fatigue syndrome. Prostaglandins Leukot Essent Fatty Acids (2004) 0.99

Human basal ganglia volume asymmetries on magnetic resonance images. Magn Reson Imaging (1993) 0.95

Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates. Neuropsychopharmacology (2013) 0.93

Interferon-α (IFNα) neurotoxicity. Cytokine Growth Factor Rev (2012) 0.89

The trajectory of apathy after deep brain stimulation: from pre-surgery to 6 months post-surgery in Parkinson's disease. Parkinsonism Relat Disord (2011) 0.88

Neuropsychological performance in persons with chronic fatigue syndrome: results from a population-based study. Psychosom Med (2008) 0.86